Welcome to our dedicated page for HELIX ACQUISITION III news (Ticker: HLXC), a resource for investors and traders seeking the latest updates and insights on HELIX ACQUISITION III stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect HELIX ACQUISITION III's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of HELIX ACQUISITION III's position in the market.
Helix Acquisition Corp. III (Nasdaq: HLXC) closed its initial public offering on January 26, 2026, selling 17,250,000 Class A ordinary shares at $10.00 per share, including the full 2,250,000‑share over‑allotment, producing $172,500,000 gross proceeds before underwriting discounts and offering expenses. Concurrently the sponsor purchased 497,500 Class A shares in a private placement at $10.00 for $4,975,000. The Class A shares began trading on Nasdaq under HLXC on January 23, 2026. A total of $172,500,000 of net proceeds from the IPO and private placement was placed in trust. An audited balance sheet as of January 26, 2026 will be filed on Form 8‑K.
Helix Acquisition Corp. III (NASDAQ: HLXC) priced an upsized initial public offering of 15,000,000 Class A ordinary shares at $10.00 per share, implying gross proceeds of approximately $150 million. The shares begin trading on The Nasdaq Global Market under the ticker HLXC on January 23, 2026, and the company expects to consummate the offering on January 26, 2026.
The sponsor is Helix Holdings III LLC, affiliated with Cormorant Asset Management, with management led by Bihua Chen (CEO and chair) and Caleb Tripp (CFO and COO). Leerink Partners and Oppenheimer & Co. are joint bookrunners. The underwriters have a 45-day option to purchase up to an additional 2,250,000 shares to cover over-allotments.
FAQ
What is the current stock price of HELIX ACQUISITION III (HLXC)?
What is the market cap of HELIX ACQUISITION III (HLXC)?
